Plain-English translation of NCT07779343 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
OBESIAL is testing a comprehensive, team-based approach to weight loss that brings together doctors, nutritionists, and exercise specialists to support adults with obesity. Some participants will receive this program alone, while others will also receive semaglutide, a medication that helps reduce appetite. The trial will follow 300 people for 18 months to see who loses the most weight and feels healthier.
Many people struggle to lose weight with standard care alone. This trial aims to understand whether a coordinated, multidisciplinary program—especially when paired with this medication—can help more people achieve meaningful, lasting weight loss and improve their overall health.
You likely qualify if…
You likely don't qualify if…
You would attend regular medical visits and meet with a nutrition specialist and exercise coach to develop a personalized plan tailored to your needs. You would also participate in educational sessions with the care team. At month 6, your progress would be reviewed. Depending on which group you're assigned to, you might also take the medication semaglutide as part of your treatment. The entire program lasts 18 months, and researchers will track your weight, blood sugar, and overall health throughout.
AI-generated summary from trial data · Sep 2, 2026 · Not medical advice
Algeria